An open-labeled, multicenter phase II study of tamibarotene in patients with steroid-refractory chronic graft-versus-host disease
- Yoshinobu Maeda
- , Hisakazu Nishimori
- , Yoshihiro Inamoto
- , Hirohisa Nakamae
- , Masashi Sawa
- , Yasuo Mori
- , Kazuteru Ohashi
- , Shin ichiro Fujiwara
- , Mitsune Tanimoto
Research output: Contribution to journal › Article › peer-review
3
Link opens in a new tab
Citations
(Scopus)